retatrutide phase 2 trial weight loss for Loss: TRIUMPH-1 Results, Cost, Insurance retatrutide phase 2 trial type

The study provides the first characterization of nationwide GLP-1 use and spending among individuals without diabetes to guide ongoing debates about balancing the sustainability of health care spending against improving accessibility and affordability of GLP-1 medications going forward, researchers concluded

That helps regulate blood sugar and reduce appetite, which can lead to weight loss

This medication is injected subcutaneously in the upper arm, abdomen, or thigh

60% fat by calories) for 36 weeks prior to the study start

Ocular complications from GLP-1 receptor agonists: Clinical evidence, potential mechanisms, and clinical recommendations

What's my timeline